Pain Self-Management and Patient-Oriented Dosing for Pain and in Retention Opioid Treatment (NCT06367387)
Pain Self-Management and Patient-Oriented Dosing for Pain and Retention in Office-based Addiction Treatment: a Randomized Trial
🩺 Plain-English Summary (8th-Grade Level)
This study seeks to improve the treatment of chronic pain in people who are taking buprenorphine (also known as Suboxone, Subutex, Zubsolv). The research study is testing two different interventions along with usual clinical care: 1. Pain Self-Management (PSM): an educational program in which individuals with chronic pain work with a trained pain coach and a pain peer to explore strategies to effectively manage the daily problems that arise from chronic pain. 2. Patient-Oriented Dosing (POD): an alternative dosing of buprenorphine which will be adjusted based on pain levels. The interventions will take place over a period of 12 weeks (3 months). Additionally, participants will complete surveys every 3 months for a period of 1 year (total of 5 survey visits). Participants will receive $50 compensation for each survey visit completed (up to $250 over one year) and can receive up to an additional $100 bonus compensation. There are risks associated with participating in the study, including breach of confidentiality, psychological distress caused by discussing difficult topics, and risks associated with the POD intervention.
Who can join: Review the eligibility criteria below.
Location: Alcohol and Drug Abuse Program (ADAP) - UM Addiction Treatment Center — Baltimore, Maryland
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (13 Sites)
- Alcohol and Drug Abuse Program (ADAP) - UM Addiction Treatment Center — Baltimore, Maryland
- MATClinics — Dundalk, Maryland
- Wells House — Hagerstown, Maryland
- Central City Concern (CCC) — Portland, Oregon
- Recovery Works Northwest (RWNW) — Portland, Oregon
- OHSU Harm Reduction Bridges to Care (HRBR) — Portland, Oregon
- OHSU Internal Medicine Clinic (IMC) — Portland, Oregon
- UPMC Latterman Family Health Center — McKeesport, Pennsylvania
- UPMC St. Margaret Family Health Center — New Kensington, Pennsylvania
- UPMC Magee-Womens Pregnancy and Women's Recovery Center (PWRC) — Pittsburgh, Pennsylvania
- UPMC Internal Medicine Recovery Engagement Program (IM-REP) — Pittsburgh, Pennsylvania
- WVU Crisis Support & Recovery Center — Martinsburg, West Virginia
- WVU Chestnut Ridge Comprehensive Addiction Treatment Program (COAT) — Morgantown, West Virginia
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Opioid Use Disorder
- Therapy and Peer Support for Patients Taking Medication for Opioid Use Disorder — Atlantic City, New Jersey
- The Emergency Department Longitudinal Integrated Care — Seattle, Washington
- Virtual Reality Cognitive-Affective Training for Opioid Use Disorder- A Phase 2 RCT — La Jolla, California
- Extended-release Buprenorphine as a Novel Low-dose Induction Strategy — Boston, Massachusetts
- Healing Opioid Misuse and Pain Through Engagement (HOPE) Trial — Ann Arbor, Michigan
- Telemedicine XR-B for Individuals in Jail — Cumberland, Maryland
Explore by condition: All Opioid Use Disorder clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.